Companies: 10,795·Total market cap: $144.5T
Castle Biosciences, Inc.

Castle Biosciences, Inc.

CSTLNASDAQHealthcare● Active
$20.12
$-0.89(-4.24%)
Market Cap$610238634
P/E Ratio
52W High$44.28
52W Low$14.59
Overview

Castle Biosciences, Inc. (CSTL) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · CSTL · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.43cstl eps ttm · cstl earnings per shareEarnings history
PE Ratio (TTM)cstl pe ratio ttm · cstl price to earningsPE Ratio deep dive
Revenue (TTM)$339.9Mcstl revenue ttm · cstl annual revenueFull revenue history
Dividend YieldNo Dividenddoes cstl pay dividends · cstl dividend yieldDividend history
Shares Outstanding29.0Mcstl shares outstanding · cstl floatShares outstanding history
Next EarningsAug 3, 2026Est.cstl earnings date · cstl next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$344.2M▲ +3.66% YoY
202320242025
castle biosciences, inc. revenue · cstl revenue 2025
FY 2025Net Income-$24.2M▼ 232.41% YoY
202320242025
castle biosciences, inc. net income · cstl profit 2025
FY 2025EPS$-0.83▼ 225.76% YoY
202320242025
cstl eps · castle biosciences, inc. earnings per share 2025
TTM:Revenue: $339.9MNet Income: -$12.8MEPS: $-0.43View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy11 analystsis cstl a buy · cstl analyst rating
Strong Buy
0
Buy
11
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$35.00Low
$20.12Current
$44.80Avg Target122.66% upside
$52.00High
cstl price target · cstl 12 month forecast

Total: 11 · Buy rate: 100.0%

The CSTL analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month price target is $44.80, representing +122.66% upside from the current price of $20.12.

Stock Performance

Full History
1D-3.43%
1W+3.20%
1M+2.32%
3M-25.18%
YTD-47.84%
1Y+11.67%
5Y-72.13%

About Castle Biosciences, Inc.

CEODerek J. Maetzold
IPO DateJul 25, 2019
Employees784
CountryUS

Castle Biosciences, Inc. functions as a commercial-stage diagnostics firm, with its primary objective being the provision of both diagnostic and prognostic testing services, specifically targeting var…

what is castle biosciences, inc. · cstl stock overview · castle biosciences, inc. company profile · who is castle biosciences, inc. ceo · cstl NASDAQ · castle biosciences, inc. headquarters · castle biosciences, inc. business segments

About Stock Overview & Key Data

Castle Biosciences, Inc. (CSTL) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Jul 25, 2019. As of the latest trading session, CSTL stock price is $20.12, with a market capitalization of $610.2M. The stock has returned +11.67% over the past 12 months and -47.84% year-to-date.

According to 11 Wall Street analysts, the consensus rating for Castle Biosciences, Inc. stock is Buy, with an average 12-month price target of $44.80. In fiscal year 2025, Castle Biosciences, Inc. reported revenue of $344.2M and net income of -$24.2M. For detailed data — including Castle Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Castle Biosciences, Inc. (CSTL) stock price is $20.12. The stock is traded on NASDAQ under the ticker symbol CSTL. The 52-week range is $14.59 – $44.28.

CSTL stock priceCSTL quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice